English

Eligibility Diabetes Mellitus, Type 2 NCT00573950

1 forms  
Criteria
Description

Criteria

type 2 diabetes (at least 1 criteria below)
Description

Diabetes Mellitus, Non-Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0011860
1. fasting blood glucose ≥ 126 mg/dl
Description

Fasting blood glucose measurement

Data type

boolean

Alias
UMLS CUI [1]
C0428568
2. postprandial 2hour glucose ≥ 200 mg/dl
Description

2-hour postprandial blood glucose measurement

Data type

boolean

Alias
UMLS CUI [1]
C2238058
3. random blood glucose ≥ 200 mg/dl with typical diabetes symptoms
Description

Random blood glucose measurement | Diabetes Mellitus Symptoms typical

Data type

boolean

Alias
UMLS CUI [1]
C0428567
UMLS CUI [2,1]
C0011849
UMLS CUI [2,2]
C1457887
UMLS CUI [2,3]
C3538928
metabolic syndrome : asian-pacific atp iii guideline
Description

Metabolic Syndrome

Data type

boolean

Alias
UMLS CUI [1]
C0524620
1. fasting blood glucose ≥ 110 mg/dl, or previously diagnosed type 2 diabetes
Description

Fasting blood glucose measurement | Diabetes Mellitus, Non-Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0428568
UMLS CUI [2]
C0011860
2. systolic and/or diastolic blood pressure ≥130/85 mmhg, or treatment of previously diagnosed hypertension
Description

Systolic Pressure | Diastolic blood pressure | Therapeutic procedure Hypertensive disease

Data type

boolean

Alias
UMLS CUI [1]
C0871470
UMLS CUI [2]
C0428883
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C0020538
3. triglyceride ≥ 150 mg/dl, or specific treatment for this lipid abnormality
Description

Triglycerides measurement | Therapeutic procedure Specific Lipids abnormal

Data type

boolean

Alias
UMLS CUI [1]
C0202236
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0205369
UMLS CUI [2,3]
C0549634
4. hdl-cholesterol < 40 mg/dl for men and < 50 mg/dl for women, or specific treatment for this lipid abnormality
Description

Serum HDL cholesterol measurement | Gender | Therapeutic procedure Specific Lipids abnormal

Data type

boolean

Alias
UMLS CUI [1]
C0428472
UMLS CUI [2]
C0079399
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C0205369
UMLS CUI [3,3]
C0549634
5. waist circumference ≥ 90 for men and ≥ 80 for women
Description

Waist Circumference | Gender

Data type

boolean

Alias
UMLS CUI [1]
C0455829
UMLS CUI [2]
C0079399
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
hypertensive patients with the use of ace inhibitor or arb
Description

Hypertensive disease | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist

Data type

boolean

Alias
UMLS CUI [1]
C0020538
UMLS CUI [2]
C0003015
UMLS CUI [3]
C0521942
hyperlipidemic patients with the use of statin or fenofibrate
Description

Hyperlipidemia | Statin | Fenofibrate

Data type

boolean

Alias
UMLS CUI [1]
C0020473
UMLS CUI [2]
C0360714
UMLS CUI [3]
C0033228
hepatic dysfunction
Description

Liver Dysfunction

Data type

boolean

Alias
UMLS CUI [1]
C0086565
chronic alcohol or drug abuse
Description

Substance Use Disorders chronic

Data type

boolean

Alias
UMLS CUI [1,1]
C0038586
UMLS CUI [1,2]
C0205191
renal dysfunction
Description

Renal dysfunction

Data type

boolean

Alias
UMLS CUI [1]
C3279454
heart failure
Description

Heart failure

Data type

boolean

Alias
UMLS CUI [1]
C0018801
patients who takes hormone replace therapy or steroid containing drugs
Description

Hormone replacement therapy | Pharmaceutical Preparations Containing Steroids

Data type

boolean

Alias
UMLS CUI [1]
C0282402
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0332256
UMLS CUI [2,3]
C0038317
patients who take drugs like anticoagulant (warfarin), anti-platelet agent (aspirin, ticlopidin), thrombolytic agent (urikinase, alteplase), prostaglandine e1 , drugs inhibit cyp3a4 or cyp2c19, or drugs become substrate of cyp3a4
Description

Anticoagulants | Warfarin | Antiplatelet Agents | Aspirin | Ticlopidine | Thrombolytic Agent | Urokinase | alteplase | Alprostadil | Cytochrome P450 3A4 Inhibitor | CYP2C19 Inhibitors | CYP3A4 Substrate

Data type

boolean

Alias
UMLS CUI [1]
C0003280
UMLS CUI [2]
C0043031
UMLS CUI [3]
C0085826
UMLS CUI [4]
C0004057
UMLS CUI [5]
C0040207
UMLS CUI [6]
C3536865
UMLS CUI [7]
C0042071
UMLS CUI [8]
C0032143
UMLS CUI [9]
C0002335
UMLS CUI [10]
C3830624
UMLS CUI [11]
C3850059
UMLS CUI [12,1]
C3714798
UMLS CUI [12,2]
C3891814
patients who haves disease influencing the results of the study such as neurologic, digestive and neoplastic disease
Description

Disease Affecting Research results | nervous system disorder | Digestive System Disorders | Neoplastic disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0683954
UMLS CUI [2]
C0027765
UMLS CUI [3]
C0012242
UMLS CUI [4]
C1882062
Back to the top of the page

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00573950

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes (at least 1 criteria below)
boolean
C0011860 (UMLS CUI [1])
Fasting blood glucose measurement
Item
1. fasting blood glucose ≥ 126 mg/dl
boolean
C0428568 (UMLS CUI [1])
2-hour postprandial blood glucose measurement
Item
2. postprandial 2hour glucose ≥ 200 mg/dl
boolean
C2238058 (UMLS CUI [1])
Random blood glucose measurement | Diabetes Mellitus Symptoms typical
Item
3. random blood glucose ≥ 200 mg/dl with typical diabetes symptoms
boolean
C0428567 (UMLS CUI [1])
C0011849 (UMLS CUI [2,1])
C1457887 (UMLS CUI [2,2])
C3538928 (UMLS CUI [2,3])
Metabolic Syndrome
Item
metabolic syndrome : asian-pacific atp iii guideline
boolean
C0524620 (UMLS CUI [1])
Fasting blood glucose measurement | Diabetes Mellitus, Non-Insulin-Dependent
Item
1. fasting blood glucose ≥ 110 mg/dl, or previously diagnosed type 2 diabetes
boolean
C0428568 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
Systolic Pressure | Diastolic blood pressure | Therapeutic procedure Hypertensive disease
Item
2. systolic and/or diastolic blood pressure ≥130/85 mmhg, or treatment of previously diagnosed hypertension
boolean
C0871470 (UMLS CUI [1])
C0428883 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C0020538 (UMLS CUI [3,2])
Triglycerides measurement | Therapeutic procedure Specific Lipids abnormal
Item
3. triglyceride ≥ 150 mg/dl, or specific treatment for this lipid abnormality
boolean
C0202236 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0205369 (UMLS CUI [2,2])
C0549634 (UMLS CUI [2,3])
Serum HDL cholesterol measurement | Gender | Therapeutic procedure Specific Lipids abnormal
Item
4. hdl-cholesterol < 40 mg/dl for men and < 50 mg/dl for women, or specific treatment for this lipid abnormality
boolean
C0428472 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C0205369 (UMLS CUI [3,2])
C0549634 (UMLS CUI [3,3])
Waist Circumference | Gender
Item
5. waist circumference ≥ 90 for men and ≥ 80 for women
boolean
C0455829 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Hypertensive disease | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist
Item
hypertensive patients with the use of ace inhibitor or arb
boolean
C0020538 (UMLS CUI [1])
C0003015 (UMLS CUI [2])
C0521942 (UMLS CUI [3])
Hyperlipidemia | Statin | Fenofibrate
Item
hyperlipidemic patients with the use of statin or fenofibrate
boolean
C0020473 (UMLS CUI [1])
C0360714 (UMLS CUI [2])
C0033228 (UMLS CUI [3])
Liver Dysfunction
Item
hepatic dysfunction
boolean
C0086565 (UMLS CUI [1])
Substance Use Disorders chronic
Item
chronic alcohol or drug abuse
boolean
C0038586 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
Renal dysfunction
Item
renal dysfunction
boolean
C3279454 (UMLS CUI [1])
Heart failure
Item
heart failure
boolean
C0018801 (UMLS CUI [1])
Hormone replacement therapy | Pharmaceutical Preparations Containing Steroids
Item
patients who takes hormone replace therapy or steroid containing drugs
boolean
C0282402 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0332256 (UMLS CUI [2,2])
C0038317 (UMLS CUI [2,3])
Anticoagulants | Warfarin | Antiplatelet Agents | Aspirin | Ticlopidine | Thrombolytic Agent | Urokinase | alteplase | Alprostadil | Cytochrome P450 3A4 Inhibitor | CYP2C19 Inhibitors | CYP3A4 Substrate
Item
patients who take drugs like anticoagulant (warfarin), anti-platelet agent (aspirin, ticlopidin), thrombolytic agent (urikinase, alteplase), prostaglandine e1 , drugs inhibit cyp3a4 or cyp2c19, or drugs become substrate of cyp3a4
boolean
C0003280 (UMLS CUI [1])
C0043031 (UMLS CUI [2])
C0085826 (UMLS CUI [3])
C0004057 (UMLS CUI [4])
C0040207 (UMLS CUI [5])
C3536865 (UMLS CUI [6])
C0042071 (UMLS CUI [7])
C0032143 (UMLS CUI [8])
C0002335 (UMLS CUI [9])
C3830624 (UMLS CUI [10])
C3850059 (UMLS CUI [11])
C3714798 (UMLS CUI [12,1])
C3891814 (UMLS CUI [12,2])
Disease Affecting Research results | nervous system disorder | Digestive System Disorders | Neoplastic disease
Item
patients who haves disease influencing the results of the study such as neurologic, digestive and neoplastic disease
boolean
C0012634 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0683954 (UMLS CUI [1,3])
C0027765 (UMLS CUI [2])
C0012242 (UMLS CUI [3])
C1882062 (UMLS CUI [4])
Back to the top of the page